Flupamesone
Chemical compound
Clinical data | |
---|---|
Trade names | Flutenal |
Other names | UR-105; Triamcinolone acetonide metembonate; 4,4'-Methylene-bis((9α-fluoro-11β,21-dihydroxy-16α,17α-isopropylidenedioxypregna-1,4-diene-3,20-dione)3-methoxy-2-naphthoate); 21,21'-[Methylenebis[(2-methoxy-1,3-naphthalenediyl)- carbonyloxy]]bis[9α-fluoro-11β-hydroxy-16α,17α-[(1-methylethylidene)- bis(oxy)]pregna-1,4-diene-3,20-dione |
Routes of administration | Topical[1] |
Drug class | Corticosteroid; Glucocorticoid |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.054.209 |
Chemical and physical data | |
Formula | C73H78F2O16 |
Molar mass | 1249.408 g·mol−1 |
3D model (JSmol) |
|
| |
InChI
|
Flupamesone (brand name Flutenal), also known as triamcinolone acetonide metembonate, is a synthetic glucocorticoid corticosteroid which is marketed in Spain.[2][3][4][1] It is a dimer of a C21 ester of triamcinolone acetonide.[2][3][1]
References
- ^ a b c Rimbau V, Lleonart F (1975). "Kinetic study of the percutaneous absorption of 1,2,4-3H-labelled flupamesone". Arzneimittelforschung. 25 (7): 1040–2. PMID 1174410.
- ^ a b J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 568–. ISBN 978-1-4757-2085-3.
- ^ a b Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 461–. ISBN 978-3-88763-075-1.
- ^ [1][dead link]
- v
- t
- e
- Antagonists: Aglepristone
- Ketoconazole
- Mifepristone
- Ulipristal acetate
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
- See also
- Glucocorticoid receptor modulators
- Mineralocorticoids and antimineralocorticoids
- List of corticosteroids
This article about a steroid is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e